Chicago Partners Investment Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,836
Closed -$255K 974
2024
Q4
$255K Buy
+1,836
New +$255K 0.01% 725